Free Trial

Nu Skin Enterprises (NYSE:NUS) Upgraded by Wall Street Zen to Strong-Buy Rating

Nu Skin Enterprises logo with Consumer Staples background

Key Points

  • Nu Skin Enterprises' stock rating has been upgraded from "buy" to a "strong-buy" by Wall Street Zen, signaling a positive outlook from analysts.
  • The company's recent earnings report showed earnings per share of $0.43, exceeding expectations of $0.25, with revenue reaching $386.14 million.
  • Insider trading activity includes the sale of 20,000 shares by EVP Chayce David Clark, indicating a 7.90% decrease in their ownership in the company.
  • Interested in Nu Skin Enterprises? Here are five stocks we like better.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating in a report released on Saturday.

Separately, Zacks Research upgraded Nu Skin Enterprises to a "hold" rating in a report on Tuesday, August 12th. Three equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Nu Skin Enterprises has a consensus rating of "Hold" and a consensus price target of $6.88.

Check Out Our Latest Stock Analysis on NUS

Nu Skin Enterprises Price Performance

Shares of NUS stock traded up $0.84 during trading hours on Friday, hitting $13.68. 309,940 shares of the company's stock were exchanged, compared to its average volume of 645,856. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. The firm has a market cap of $677.16 million, a P/E ratio of 6.80 and a beta of 0.92. The firm has a 50 day moving average of $10.61 and a two-hundred day moving average of $8.48. Nu Skin Enterprises has a fifty-two week low of $5.32 and a fifty-two week high of $14.62.

Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.43 earnings per share for the quarter, topping the consensus estimate of $0.25 by $0.18. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%.The business had revenue of $386.14 million during the quarter, compared to the consensus estimate of $376.68 million. Nu Skin Enterprises has set its FY 2025 guidance at 1.150-1.350 EPS. Sell-side analysts forecast that Nu Skin Enterprises will post 1.05 EPS for the current year.

Insider Activity at Nu Skin Enterprises

In related news, Director Laura Nathanson sold 6,489 shares of the firm's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $12.22, for a total transaction of $79,295.58. Following the completion of the transaction, the director directly owned 33,149 shares in the company, valued at $405,080.78. This trade represents a 16.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Daniel W. Campbell sold 23,391 shares of the firm's stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $12.10, for a total value of $283,031.10. Following the transaction, the director owned 53,375 shares of the company's stock, valued at $645,837.50. This trade represents a 30.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 58,926 shares of company stock worth $711,364 in the last three months. 2.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Nu Skin Enterprises

Hedge funds have recently bought and sold shares of the stock. Atlantic Union Bankshares Corp acquired a new stake in Nu Skin Enterprises in the 2nd quarter valued at about $25,000. GAMMA Investing LLC raised its position in Nu Skin Enterprises by 102.0% in the 1st quarter. GAMMA Investing LLC now owns 3,498 shares of the company's stock valued at $25,000 after purchasing an additional 1,766 shares in the last quarter. New York State Teachers Retirement System acquired a new stake in Nu Skin Enterprises in the 1st quarter valued at about $33,000. Tower Research Capital LLC TRC raised its position in Nu Skin Enterprises by 107.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 5,048 shares of the company's stock valued at $40,000 after purchasing an additional 2,614 shares in the last quarter. Finally, Public Employees Retirement System of Ohio raised its position in Nu Skin Enterprises by 28.5% in the 4th quarter. Public Employees Retirement System of Ohio now owns 7,976 shares of the company's stock valued at $55,000 after purchasing an additional 1,768 shares in the last quarter. Institutional investors and hedge funds own 82.84% of the company's stock.

About Nu Skin Enterprises

(Get Free Report)

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.

Featured Stories

Should You Invest $1,000 in Nu Skin Enterprises Right Now?

Before you consider Nu Skin Enterprises, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.

While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.